Diet and gut bacteria in pancreatic cancer treatment
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how diet and the bacteria in your gut might affect how well chemotherapy works for pancreatic cancer that can be surgically removed. If you have been newly diagnosed with this type of pancreatic cancer, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older and willing to sign a consent form
- Has pancreatic ductal adenocarcinoma (a common type of pancreatic cancer)
- The cancer is either removable with surgery or likely removable after some chemotherapy
- Has not already received chemotherapy for this pancreatic cancer
- Has no other active cancer that requires treatment with medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This trial tests a combination of three chemotherapy drugs given before surgery for pancreatic cancer that is removable or borderline removable. The goal is to shrink the tumor to make surgery more successful.
This trial tests a combination of chemotherapy drugs (NALIRIFOX) given before surgery to shrink the tumor in people with a specific type of pancreatic cancer. The goal is to make surgery more effective and improve outcomes.
This trial tests whether choosing chemotherapy based on a SMAD4 gene change in your tumor works better than the usual approach for pancreatic cancer that can be surgically removed. If you have the gene change, you may get a different chemotherapy combination to improve outcomes.
This study looks at how the bacteria in your gut relate to your nutritional health during chemotherapy for digestive cancers. It may help improve future care by understanding this connection.
This trial looks at gut bacteria in people having surgery for pancreatic cancer. It aims to understand how these bacteria might affect recovery or treatment outcomes.
Hear when a new Borderline Resectable Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.